Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000928570 | SCV001074182 | likely benign | not provided | 2023-12-26 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002489232 | SCV002802904 | likely benign | Autosomal dominant Alport syndrome; Autosomal recessive Alport syndrome; Benign familial hematuria | 2021-12-15 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000928570 | SCV004151539 | likely benign | not provided | 2022-12-01 | criteria provided, single submitter | clinical testing | COL4A3: BP4, BP7 |
Natera, |
RCV001272222 | SCV001453997 | likely benign | Alport syndrome | 2020-09-16 | no assertion criteria provided | clinical testing |